top of page

Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

Givol Moked01
Sep 18
0 min read

Recent Posts

Form 6-K- Financial and operating results for the first half of 2025

Form 6-K- Financial and operating results for the first half of 2025

Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025

Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025

FORM 20-F

bottom of page